Mangoceuticals  logo
MGRXMangoceuticals
Trade MGRX now
Mangoceuticals  primary media

About Mangoceuticals

Mangoceuticals (NASDAQ:MGRX) focuses on the development and commercialization of innovative pharmaceutical and healthcare products. With a diverse portfolio that spans from groundbreaking therapies to wellness products, Mangoceuticals aims to improve the quality of life by addressing unmet medical needs. Its projects range from early-stage drug discovery to advanced clinical trials, targeting a variety of therapeutic areas. Besides its primary listing, Mangoceuticals is committed to expanding its impact, striving to become a household name in health and wellness solutions while maintaining a strong ethical framework and sustainability in its operations.

What is MGRX known for?

Snapshot

Public US
Ownership
2021
Year founded
3
Employees
Dallas, United States
Head office
1 of 1
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Dallas, US

Products and/or services of Mangoceuticals

  • Development of innovative oncology treatments targeting rare and difficult to treat cancers.
  • Research and production of advanced skincare products incorporating novel biotech ingredients.
  • Partnership initiatives for global distribution of its patented pharmaceutical products.
  • Creation of a state-of-the-art biotechnology research facility focused on genetic and cell therapy.
  • Investment in AI-driven drug discovery platforms to accelerate the development of new medications.
  • Launching a telemedicine service offering personalized healthcare consultations and prescription services.

Mangoceuticals executive team

  • Mr. Jacob D. CohenCo-Founder, CEO & Chairman
  • Mr. Eugene M. JohnstonChief Financial Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.